{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:25:01Z","timestamp":1781843101721,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11307-020-01502-y","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T14:03:23Z","timestamp":1590674603000},"page":"1592-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5836-0792","authenticated-orcid":false,"given":"Nicolas","family":"Nicastro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre R.","family":"Burkhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Garibotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"1502_CR1","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/jama.284.15.1931","volume":"284","author":"Parkinson Study Group","year":"2000","unstructured":"Parkinson Study Group (2000) Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA 284:1931\u20131938","journal-title":"JAMA"},{"key":"1502_CR2","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","volume":"287","author":"Parkinson Study Group","year":"2002","unstructured":"Parkinson Study Group (2002) Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. JAMA 287:1653\u20131661","journal-title":"JAMA"},{"key":"1502_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","volume":"87","author":"R Erro","year":"2016","unstructured":"Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP (2016) What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies. J Neurol Neurosurg Psychiatry 87:319\u2013323","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1502_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","volume":"82","author":"K Marek","year":"2014","unstructured":"Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, Hyson C, Jennings D, For The Parkinson Study Group PRECEPT Investigators (2014) Longitudinal follow-up of SWEDD subjects in the PRECEPT study. Neurology 82:1791\u20131797","journal-title":"Neurology"},{"key":"1502_CR5","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00415-011-6076-z","volume":"258","author":"F Sixel-Doring","year":"2011","unstructured":"Sixel-Doring F, Liepe K, Mollenhauer B, Trautmann E, Trenkwalder C (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258:2147\u20132154","journal-title":"J Neurol"},{"key":"1502_CR6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/mds.26018","volume":"29","author":"A Batla","year":"2014","unstructured":"Batla A, Erro R, Stamelou M, Schneider SA, Schwingenschuh P, Ganos C, Bhatia KP (2014) Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study. Mov Disord 29:1820\u20131825","journal-title":"Mov Disord"},{"key":"1502_CR7","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","volume":"27","author":"VL Marshall","year":"2006","unstructured":"Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933\u2013937","journal-title":"Nucl Med Commun"},{"key":"1502_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2017.11.039","volume":"385","author":"N Nicastro","year":"2018","unstructured":"Nicastro N, Burkhard PR, Garibotto V (2018) Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: a prospective study. J Neurol Sci 385:17\u201321","journal-title":"J Neurol Sci"},{"key":"1502_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.parkreldis.2016.07.002","volume":"31","author":"N Nicastro","year":"2016","unstructured":"Nicastro N, Garibotto V, Badoud S, Burkhard PR (2016) Scan without evidence of dopaminergic deficit: a 10-year retrospective study. Parkinsonism Relat Disord 31:53\u201358","journal-title":"Parkinsonism Relat Disord"},{"key":"1502_CR10","first-page":"56","volume":"6","author":"M Menendez-Gonzalez","year":"2014","unstructured":"Menendez-Gonzalez M, Tavares F, Zeidan N, Salas-Pacheco JM, Arias-Carrion O (2014) Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study. Front Aging Neurosci 6:56","journal-title":"Front Aging Neurosci"},{"key":"1502_CR11","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00259-014-2785-8","volume":"41","author":"W Koch","year":"2014","unstructured":"Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Hesse S, Vander Borght T, van Laere K, Tatsch K, la Foug\u00e8re C (2014) Extrastriatal binding of [(1)(2)(3)I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. Eur J Nucl Med Mol Imaging 41:1938\u20131946","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1502_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","volume":"60","author":"L Kerenyi","year":"2003","unstructured":"Kerenyi L, Ricaurte GA, Schretlen DJ et al (2003) Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol 60:1223\u20131229","journal-title":"Arch Neurol"},{"key":"1502_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","volume":"14","author":"M Guttman","year":"2007","unstructured":"Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ (2007) Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. Eur J Neurol 14:523\u2013528","journal-title":"Eur J Neurol"},{"key":"1502_CR14","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s11307-017-1052-3","volume":"19","author":"E Premi","year":"2017","unstructured":"Premi E, Calhoun VD, Garibotto V, Turrone R, Alberici A, Cottini E, Pilotto A, Gazzina S, Magoni M, Paghera B, Borroni B, Padovani A (2017) Source-based Morphometry multivariate approach to analyze [(123)I]FP-CIT SPECT imaging. Mol Imaging Biol 19:772\u2013778","journal-title":"Mol Imaging Biol"},{"key":"1502_CR15","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00259-019-04324-5","volume":"46","author":"A Pilotto","year":"2019","unstructured":"Pilotto A, di Cola FS, Premi E et al (2019) Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a (123)I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 46:1642\u20131651","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1502_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635","journal-title":"Prog Neurobiol"},{"key":"1502_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.neuroimage.2016.12.077","volume":"147","author":"G Gonzalez-Escamilla","year":"2017","unstructured":"Gonzalez-Escamilla G, Lange C, Teipel S, Buchert R, Grothe MJ, Alzheimer's Disease Neuroimaging Initiative (2017) PETPVE12: an SPM toolbox for partial volume effects correction in brain PET - application to amyloid imaging with AV45-PET. Neuroimage 147:669\u2013677","journal-title":"Neuroimage"},{"key":"1502_CR18","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, Segonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968\u2013980","journal-title":"Neuroimage"},{"key":"1502_CR19","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/brain\/awv183","volume":"138","author":"M Beaudoin-Gobert","year":"2015","unstructured":"Beaudoin-Gobert M, Epinat J, Metereau E et al (2015) Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. Brain 138:2632\u20132647","journal-title":"Brain"},{"key":"1502_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00259-016-3309-5","volume":"43","author":"R Buchert","year":"2016","unstructured":"Buchert R, Kluge A, Tossici-Bolt L, Dickson J, Bronzel M, Lange C, Asenbaum S, Booij J, Atay Kapucu L\u00d6, Svarer C, Koulibaly PM, Nobili F, Pagani M, Sabri O, Sera T, Tatsch K, Vander Borght T, van Laere K, Varrone A, Iida H (2016) Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls. Eur J Nucl Med Mol Imaging 43:1323\u20131336","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1502_CR21","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain 138:2964\u20132973","journal-title":"Brain"},{"key":"1502_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","volume":"15","author":"HT Benamer","year":"2000","unstructured":"Benamer HT, Patterson J, Wyper DJ et al (2000) Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake. Mov Disord 15:692\u2013698","journal-title":"Mov Disord"},{"key":"1502_CR23","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1073\/pnas.90.24.11965","volume":"90","author":"RB Innis","year":"1993","unstructured":"Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S (1993) Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 90:11965\u201311969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1502_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marek KL, Quinlan D et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38:589\u2013598","journal-title":"Ann Neurol"},{"key":"1502_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.parkreldis.2018.02.039","volume":"51","author":"JY Lee","year":"2018","unstructured":"Lee JY, Lao-Kaim NP, Pasquini J, Deuschl G, Pavese N, Piccini P (2018) Pallidal dopaminergic denervation and rest tremor in early Parkinson\u2019s disease: PPMI cohort analysis. Parkinsonism Relat Disord 51:101\u2013104","journal-title":"Parkinsonism Relat Disord"},{"key":"1502_CR26","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/mds.23179","volume":"25","author":"F Roselli","year":"2010","unstructured":"Roselli F, Pisciotta NM, Pennelli M, Aniello MS, Gigante A, de Caro MF, Ferrannini E, Tartaglione B, Niccoli-Asabella A, Defazio G, Livrea P, Rubini G (2010) Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study. Mov Disord 25:1853\u20131859","journal-title":"Mov Disord"},{"key":"1502_CR27","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/mds.21685","volume":"22","author":"SA Schneider","year":"2007","unstructured":"Schneider SA, Edwards MJ, Mir P, Cordivari C, Hooker J, Dickson J, Quinn N, Bhatia KP (2007) Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22:2210\u20132215","journal-title":"Mov Disord"},{"key":"1502_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fneur.2018.00335","volume":"9","author":"M Menendez-Gonzalez","year":"2018","unstructured":"Menendez-Gonzalez M, Alvarez-Avell\u00f3n T, Salas-Pacheco JM et al (2018) Frontotemporal lobe degeneration as origin of scans without evidence of dopaminergic deficit. Front Neurol 9:335","journal-title":"Front Neurol"},{"issue":"6","key":"1502_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1017\/S1355617718000164","volume":"24","author":"KA Wyman-Chick","year":"2018","unstructured":"Wyman-Chick KA, Martin PK, Min\u00e1r M, Men\u00e9ndez-Gonz\u00e1lez M, Erickson LO, \u00c1lvarez-Avell\u00f3n T, Schroeder RW (2018) Neuropsychological test performance in parkinsonism without dopaminergic deficiency on [123I]-FP-CIT SPECT imaging. J Int Neuropsychol Soc 24(6):646\u2013651","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"1502_CR30","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.26204","volume":"30","author":"FS Sprenger","year":"2015","unstructured":"Sprenger FS, Seppi K, Djamshidian A, Reiter E, Nocker M, Mair K, G\u00f6bel G, Poewe W (2015) Nonmotor symptoms in subjects without evidence of dopaminergic deficits. Mov Disord 30(7):976\u2013981","journal-title":"Mov Disord"},{"key":"1502_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10072-009-0100-4","volume":"30","author":"R Djaldetti","year":"2009","unstructured":"Djaldetti R, Treves TA, Ziv I, Melamed E, Lampl Y, Lorberboym M (2009) Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci 30:301\u2013305","journal-title":"Neurol Sci"},{"key":"1502_CR32","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mds.10531","volume":"18","author":"W Pirker","year":"2003","unstructured":"Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Br\u00fccke T (2003) Measuring the rate of progression of Parkinson\u2019s disease over a 5-year period with beta-CIT SPECT. Mov Disord 18:1266\u20131272","journal-title":"Mov Disord"},{"key":"1502_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/ane.12613","volume":"135","author":"L Ramani","year":"2017","unstructured":"Ramani L, Malek N, Patterson J, Nissen T, Newman EJ (2017) Relationship between [(123) I]-FP-CIT SPECT and clinical progression in Parkinson's disease. Acta Neurol Scand 135:400\u2013406","journal-title":"Acta Neurol Scand"},{"key":"1502_CR34","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00415-019-09348-3","volume":"266","author":"A Regnault","year":"2019","unstructured":"Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S (2019) Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. J Neurol 266:1927\u20131936","journal-title":"J Neurol"},{"key":"1502_CR35","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1088\/0031-9155\/57\/21\/R119","volume":"57","author":"K Erlandsson","year":"2012","unstructured":"Erlandsson K, Buvat I, Pretorius PH, Thomas BA, Hutton BF (2012) A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol 57:R119\u2013R159","journal-title":"Phys Med Biol"},{"key":"1502_CR36","first-page":"1129","volume":"37","author":"A Abi-Dargham","year":"1996","unstructured":"Abi-Dargham A, Gandelman MS, DeErausquin GA, Zea-Ponce Y, Zoghbi SS, Baldwin RM, Laruelle M, Charney DS, Hoffer PB, Neumeyer JL, Innis RB (1996) SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. J Nucl Med 37:1129\u20131133","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-020-01502-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-020-01502-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:40:25Z","timestamp":1622162425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-020-01502-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1502"],"URL":"https:\/\/doi.org\/10.1007\/s11307-020-01502-y","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}